Stock listing
Mymetics Corp.
Selected listing: MYMX · OTC · USD · US
Mymetics Corp. (OTC:MYMX), Health Technology. Latest release Aug 31, 2022: Mymetics and PCI Biotech Sign a Preclinical Research Collaboration.
- Ticker
- OTC:MYMX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OTC
- Currency
- USD
About Mymetics Corp.
The company focuses on developing innovative therapeutic solutions. Mymetics is actively engaged in advancing its research and product pipeline in the biotechnology sector.
Latest news from Mymetics Corp.
Mymetics and PCI Biotech Sign a Preclinical Research Collaboration
August 30, 2022
Mymetics to Advance Preclinical Studies for Virosome-based COVID-19 Vaccine through Innosuisse Grant
November 17, 2020
Mymetics Starts Second Preclinical Study for Virosome-based Covid-19 Vaccine
November 1, 2020
Mymetics Starts Preclinical Studies with Baylor College of Medicine for Virosome-based Covid-19 Vaccine
September 22, 2020
Mymetics Receives Support for Virosome-based Covid-19 Vaccine Development from European Vaccine Infrastructure Project (Transvac2)
June 10, 2020